Clinical

Dataset Information

0

Effects of OXY111A in Primary and Secondary Hepato-Pancreato-Biliary Neoplasm


ABSTRACT: The purpose of the study is to evaluate whether the novel anti-cancer drug OXY111A is safe and tolerated in patients with primary and secondary hepato-pancreato-biliary and gastrointestinal neoplasia as measured by exploring the maximum tolerated dose (MTD). At level of MTD, additional patients will be included aimed for assessing the efficacy profile in these neoplasia entities.

DISEASE(S): Colorectal Neoplasms,Carcinoma, Hepatocellular,Hepatocellular Cancer,Liver Neoplasms,Pancreatic Neoplasms,Cholangiocarcinoma,Neoplasms

PROVIDER: 2196481 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

2023-08-02 | GSE229270 | GEO
2021-07-01 | MODEL2105030001 | BioModels
2020-09-01 | GSE147969 | GEO
2022-08-03 | PXD026693 | Pride
2012-03-01 | E-GEOD-34166 | biostudies-arrayexpress
2022-08-03 | PXD026694 | Pride
2020-08-07 | GSE140001 | GEO
2019-11-12 | GSE119227 | GEO
2011-11-21 | E-GEOD-32035 | biostudies-arrayexpress
| PRJNA80809 | ENA